onfasprodil   Click here for help

GtoPdb Ligand ID: 12156

Compound class: Synthetic organic
Comment: Onfasprodil was identified from WHO proposed INN list 126 (Jan 2022) as a N-methyl-D-aspartate (NMDA) receptor antagonist. It acts as a negative allosteric modulator of the glutamate ionotropic receptor NMDA type subunit 2B (GRIN2B; GluN2B or NR2B) and is proposed as an intravenous, rapid onset antidepressant. Onfasprodil's chemical structure is claimed in patent US10239835B2 [1]. We predict that is onfasprodil Novartis' Phase 2 clinical lead MIJ821, although name-to-structure has not been disclosed.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 65.82
Molecular weight 358.17
XLogP 2.28
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Oc1ccc(nc1)[C@H](CN1C[C@@H]2[C@H](C1)CC(C2)Oc1ccccc1F)O
Isomeric SMILES C1[C@@H]2CN(C[C@@H]2CC1Oc1ccccc1F)C[C@@H](c1ncc(cc1)O)O
InChI InChI=1S/C20H23FN2O3/c21-17-3-1-2-4-20(17)26-16-7-13-10-23(11-14(13)8-16)12-19(25)18-6-5-15(24)9-22-18/h1-6,9,13-14,16,19,24-25H,7-8,10-12H2/t13-,14+,16?,19-/m0/s1
InChI Key NEFQLCKWVRZEJA-ZWVKXQFTSA-N
Selectivity at ion channels
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
GluN2B Hs Allosteric modulator Negative 8.1 pIC50 - 1
pIC50 8.1 (IC50 8.3x10-9 M) [1]